Research and Clinical Trials

The Johns Hopkins Greenberg Bladder Cancer Institute is working to advance the science and clinical care of bladder cancer through cutting-edge research. While based in Baltimore, Maryland, the institute is a multidisciplinary collaboration that includes clinician-scientists from Johns Hopkins and from other top institutions and organizations around the world.


Looking toward the future

Oncologist Noah Hahn, M.D., talks about the positive influence of the Greenberg Bladder Cancer Institute and the overall state of bladder cancer research today.

Grant-Making to Recruit Investigators and Jump-Start Meaningful Research

Given the impact of the disease, there aren't nearly enough experts dedicated to bladder cancer research. Then there are researchers with novel ideas but no funding or those who - with a little more money - could launch a next-phase trial and produce real results. Through an annual grant program, we are recruiting talent to the field and helping investigators from all over kick off projects and accelerate progress on current initiatives.

Research Highlights

Mohamad E. Allaf, M.D., director of the Brady Urological Institute

Stay Up to Date with Discovery

Researchers at the Johns Hopkins Greenberg Bladder Cancer Institute, in collaboration with other leading institutions, are developing and evaluating innovative approaches to the way the world diagnoses, treats and prevents bladder cancer.

After decades of lagging behind other diseases in the pace of funding and discovery, bladder cancer is finally getting the attention and research funding it deserves. The technology and science have caught up to developments that have been made for other diseases, and targets are showing encouraging results specific to bladder cancer.

We’re making progress every day, and some of our work is already having a positive impact on patients involved with clinical trials.

Latest in Bladder Cancer Research

Get the highlights on current studies and recent developments in bladder cancer research.

Clinical Trials

The Promise of Research

No two bladder cancer cases are alike, which is why the Johns Hopkins Greenberg Bladder Cancer Institute team takes an individualized approach with each patient. Our investigators are committed to improving the lives of bladder cancer patients and believe that clinical trials are critical to realizing that goal. Within the Greenberg Institute, clinical trials are presented as an initial option to all patients. If our multidisciplinary team determines that a clinical trial option is not available for a particular patient, standard of care options always remain a therapy option. 

Clinical trials provide patients with access to new bladder cancer treatment approaches in their early stages of discovery. These may include new immunotherapy drugs or surgical techniques, novel protocols for specific cancer stages, or trials to determine the effectiveness of different treatment combinations. 

See FAQs about clinical trials. 

How to Enroll

Many of the studies available at Johns Hopkins are being directed by physicians on the Johns Hopkins Greenberg Institute team, which is dedicated to advancing bladder cancer research. Our team is very knowledgeable about trials and collaborates with many other clinical trial enrollments.

Our multi-disciplinary team of experts will discuss the pros and cons of a particular trial and whether you meet eligibility requirements. They will be with you from inception and through the clinical trial journey.

Find a Clinical Trial

Find current trials  and explore resources offered at the Johns Hopkins Kimmel Cancer Center for bladder cancer patients. 

Discovery

A publication of the Patrick C. Walsh Prostate Cancer Research Fund, the Brady Urological Institute, and Johns Hopkins Medicine.

Research Updates